ALKERMES

Ebitda Endring Dato
AbbVie USD 6.75B 433M 2023-09
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
ALKERMES USD 68.51M 189.7M 2023-09
Amgen USD 3.66B 713M 2023-12
Biogen USD 652.1M 241.8M 2023-12
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bluebird Bio USD -83657000 670K 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
Heron Therapeutics USD -24202000 17.46M 2023-09
Intra Cellular Therapies USD -33961000 4.38M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Malin Corporation EUR -2100000 800K 2023-06
Marinus Pharmaceuticals USD -31504000 192K 2023-09
Merck USD 7.51B 11.02B 2023-09
Minerva Neurosciences USD -6071000 1.56M 2023-09
Nektar Therapeutics USD -31809000 70K 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Otsuka Holdings JPY 117.02B 15.23B 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Revance Therapeutics USD -41961000 20.01M 2023-09
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



ALKERMES - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.